Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Streptococcus pneumoniae is a major cause of illness in children and the elderly.
• Pneumococcal infection involves complex bacterial and host interactions.
• CD40L (CD154) plays a role in immune responses.

Purpose of the Study:

• To investigate the role of CD40L in host defense against Streptococcus pneumoniae.
• To determine the effect of CD40L neutralization on antibody production and susceptibility to pneumococcal infection.

Main Methods:

• Mice were treated with MR-1 antibody (anti-CD40L/CD154).
• Antibody responses to pneumococcal antigens (PspA, polysaccharides) were measured after immunization.
• Mice were challenged with virulent Streptococcus pneumoniae to assess sepsis, lung infection, and nasal carriage.

Main Results:

• MR-1 treatment significantly reduced antibody responses to PspA and T-cell dependent capsular polysaccharides when presented in whole bacteria.
• Antibody responses to isolated capsular polysaccharides and cell wall polysaccharides were not suppressed.
• MR-1 treatment did not affect sepsis, lung infection, or nasal carriage in non-immune mice challenged with pneumococci.

Conclusions:

• Short-term CD40L neutralization does not impair innate host defenses against Streptococcus pneumoniae.
• Humoral responses to capsular polysaccharides are partially T-cell dependent in the context of whole bacteria.
• CD40L is important for adaptive antibody responses but not critical for innate immunity against pneumococcal invasion.